APITOPE INTERNATIONAL NV;APITOPE TECHNOLOGY (BRISTOL) LIMITED
发明人:
申请号：
IL20578010
公开号：
IL205780A
申请日:
2010.05.13
申请国别(地区):
IL
年份:
2015
代理人:
摘要：
The present invention provides a peptide comprising a core residue sequence derivable from human FVIII which peptide is capable of binding to an MHC class II molecule without further antigen processing. The present invention also relates to the use of such peptides for the prevention or suppression of inhibitor antibody formation in haemophilia A and/or acquired haemophilia.
